- Home
- ISPC vs INM Comparison
ISPC vs INM Comparison
Compare ISPC & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISPC
- INM
- Stock Information
- Founded
- ISPC 2009
- INM 1981
- Country
- ISPC United States
- INM Canada
- Employees
- ISPC N/A
- INM N/A
- Industry
- ISPC Precision Instruments
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- ISPC Health Care
- INM Health Care
- Exchange
- ISPC Nasdaq
- INM Nasdaq
- Market Cap
- ISPC 2.0M
- INM 2.3M
- IPO Year
- ISPC 2021
- INM N/A
- Fundamental
- Price
- ISPC $1.74
- INM $3.12
- Analyst Decision
- ISPC
- INM
- Analyst Count
- ISPC 0
- INM 0
- Target Price
- ISPC N/A
- INM N/A
- AVG Volume (30 Days)
- ISPC 120.7K
- INM 84.1K
- Earning Date
- ISPC 03-12-2025
- INM 02-12-2025
- Dividend Yield
- ISPC N/A
- INM N/A
- EPS Growth
- ISPC N/A
- INM N/A
- EPS
- ISPC N/A
- INM N/A
- Revenue
- ISPC $10,390,702.00
- INM $4,832,013.00
- Revenue This Year
- ISPC $13.82
- INM N/A
- Revenue Next Year
- ISPC $11.76
- INM N/A
- P/E Ratio
- ISPC N/A
- INM N/A
- Revenue Growth
- ISPC 0.74
- INM N/A
- 52 Week Low
- ISPC $1.73
- INM $2.42
- 52 Week High
- ISPC $11.80
- INM $15.70
- Technical
- Relative Strength Index (RSI)
- ISPC 32.34
- INM 37.82
- Support Level
- ISPC $1.76
- INM $3.03
- Resistance Level
- ISPC $1.99
- INM $3.48
- Average True Range (ATR)
- ISPC 0.16
- INM 0.20
- MACD
- ISPC 0.02
- INM 0.05
- Stochastic Oscillator
- ISPC 2.13
- INM 35.59
About ISPC iSpecimen Inc.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.